Ex parte KLEID et al. - Page 5


                      Appeal No. 1999-1157                                                                                                                 
                      Application No. 08/482,321                                                                                                           


                      meets this limitation of appellants’ claimed invention.  Cohen and Goeddel fail to                                                   
                      make up for this deficiency in Bertrand.                                                                                             
                               The initial burden of presenting a prima facie case of obviousness rests on                                                 
                      the examiner.  In re Oetiker, 977 F.2d 1443, 1445, 24 USPQ2d 1443, 1444 (Fed.                                                        
                      Cir. 1992).  In satisfying this initial burden, every limitation positively recited in a                                             
                      claim must be given effect in order to determine what subject matter that claim                                                      
                      defines.  In re Wilder, 429 F.29 447, 450, 166 USPQ 545, 548 (CCPA 1970).  Here                                                      
                      the examiner failed to meet her burden of establishing a prima facie case of                                                         
                      obviousness.  Accordingly, we reverse the rejection of claims 1, 9, 10 and 35-37                                                     
                      under 35 U.S.C. § 103 as obvious over Cohen in view of Bertrand and Goeddel.                                                         
                      Cohen in view of Miozzari (R), Miozzari (S) and Goeddel:                                                                             
                               Miozzari (R), however, teach (Miozzari (R), figure 1) two constructs                                                        
                      trp?LE1417, and trp?LE1413.  Both of these constructs meet the limitation of                                                         
                      appellants’ claim 1 section (iv) with respect to “a structural gene … comprising 6                                                   
                      amino acids of the trp leader peptide, [and] … at least about the distal third of the                                                
                      trp E polypeptide….”  In fact, we note that appellants’ specification (page 10, lines                                                
                      28-34) discloses:                                                                                                                    
                                         Two particularly useful plasmids from which the attenuator                                                        
                               region has been deleted are the plasmids pGM1 and pGM3, G.F.                                                                
                               Miozzari et al, J. Bacteriology 133, 1457 (1978).  These respectively                                                       
                               carry the deletions trp?LE1413 and trp?LE1417 and express (under                                                            
                               the control of the trp promoter-operator) a polypeptide comprising                                                          
                               aproximately the first six amino acids of the trp leader and distal                                                         
                               regions of the E polypeptide.  In the most preferred case, pGM1, only                                                       
                               about the last third of the E polypeptide is expressed whereas pGM2                                                         
                               expresses almost the distal one half of the E polypeptide codons.                                                           

                                                                            5                                                                              



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007